ARMI | BioFabUSA will serve as a Community Champion at the 2026 Bring Back the Trades Skills Expo, helping students and adult learners explore career pathways in biomanufacturing and advanced manufacturing.
ARMI CTO Dr. Tom Bollenbach will moderate manufacturing and AI sessions at an NIH workshop focused on advancing cell-replacement therapies for type 1 diabetes.
Meet ARMI | BioFabUSA at the 2026 Cambridge Science Carnival and explore regenerative manufacturing, STEM education and biomanufacturing careers.
Join ARMI | BioFabUSA at Wicked STEM 2026 in Manchester, NH, for hands-on STEM activities and an exploration of careers in biomanufacturing.
Join ARMI at Cell & Gene Therapy International during Biotech Week Boston, where Chief Regulatory Officer Dr. Richard McFarland will moderate a panel on decentralized manufacturing for cell therapies.
ARMI plans to participate in Automation Fair® 2026, Rockwell Automation’s premier industrial operations event, bringing together manufacturing leaders, technology innovators, and automation experts to explore the future of smart manufacturing.
ARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
ARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry’s leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
ARMI Chief Operating Officer Jennifer MacDonald will participate in a panel discussion at the Cell & Gene Therapy Summit 2026, exploring the scientific, manufacturing, regulatory, and commercialization challenges involved in bringing advanced therapies to patients.
ARMI will attend BIO 2026 to connect with biotechnology leaders, explore partnership opportunities, and engage in discussions shaping the future of advanced biomanufacturing and regenerative medicine.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
